Table 2.

Prevalence among Down syndrome (DS) Sample and General Population

Clinical Disease ConditionsDSGeneral PopulationOR (95% CI)P-Value
 CHD (includes angina and MI)9/2342 (0.38%)18,200,000/271,641,791 (6.70%)0.05 (0.03, 0.10)<.0001*
 Angina2/2342 (0.09%)9,400,000/261,111,111 (3.60%)0.02 (0.01, 0.09)<.0001*
 MI1/2342 (0.04%)8,400,000/280,000,000 (3.00%)0.01 (0.00, 0.10)<.0001*
 Heart failure33/2342 (1.41%)6,200,000/281,818,181 (2.20%)0.64 (0.45, 0.90).01
 Stroke69/2342 (2.95%)7,000,000/280,000,000 (2.50%)1.18 (0.93, 1.50).17
Risk conditions
 DM117/2342 (5.00%)26,000,000/265,306,122 (9.80%)0.48 (0.40, 0.58)<.0001
 Hypertension63/2342 (2.69%)116,400,000/253,043,478 (46.0%)0.03 (0.03, 0.04)<.0001
 Overweight (BMI, 25.0 to 29.9 kg/m2)1332/1814 (73.43%)157,232,115/226,559,242 (69.40%)1.22 (1.10, 1.35).00
 Obesity (BMI, 30.0+ kg/m2)780/1814 (43.00%)82,241,005/226,559,242 (36.30%)1.32 (1.21, 1.45)<.0001
 High TC (TC ≥ 240 mg/dL)63/2342 (2.69%)28,500,000/243,589,743 (11.70%)0.21 (0.16, 0.27)<.0001
  • BMI, body mass index; CHD, coronary heart disease; DM, diabetes mellitus; MI, myocardial infarction; TC, total cholesterol; OR, odds ratio; CI, confidence interval.

  • * Indicates statistical significance at P < .05 using Fisher’s Exact test.

  • Indicates statistical significance at P < .05 using Pearson’s chi-square test.

  • General population statistics for these conditions represent 2011 to 2014 data instead of 2013 to 2016 data.